APAC CRISPR Gene Editing Market Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “APAC CRISPR Gene Editing Market 2021-2031” report has been added to from ResearchAndMarkets.com offer.

Asia-Pacific CRISPR Gene Editing Market to Grow 28.6% Annually with Total Addressable Market Cap of $21.45 Billion in 2022-2031

The market is driven by growing demand for better food and medical products, innovative advancements in gene therapy supported by continuous investments in healthcare, growing geriatric population and rise in genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid the COVID-19 pandemic.

The Asia-Pacific market trend and outlook is forecasted in an optimistic, balanced and conservative view considering COVID-19. The balanced (most likely) projection is used to quantify the Asia Pacific CRISPR Gene Editing Market in all aspects of classification from supply, application, end-user perspectives and the country.

The report also covers the current competitive scenario and the forecasted trend; and profiles key vendors, including market leaders and important emerging players.

Selected key players:

  • ABCAM, Inc.

  • Agilent Technologies, Inc.

  • Applied Stem Cells, Inc.

  • Caribou Biosciences, Inc.

  • Cellecta, Inc.

  • CRISPR Therapeutics SA

  • Editas Medicine, Inc.

  • GeneCopoeia, Inc.

  • GeneScript biotechnology company

  • Horizon Discovery Group PLC

  • Integrated DNA Technologies, Inc.

  • Intellia Therapeutics Inc.

  • Lonza Group Ltd.

  • Merck KGaA

  • New England Biolabs, Inc.

  • Origin Technologies, Inc.

  • Rockland Immunochemicals, Inc.

  • Synthego Corporation

  • System Biosciences LLC

  • Takara Bio, Inc.

  • ThermoFisher Scientific, Inc.

  • ToolGen, Inc.

Main topics covered:

1. Introduction

1.1 Industry Definition and Research Scope

1.2 Research methodology

1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on the global economy

2.1.2 Impact of COVID-19 on the market

2.2 Key Growth Drivers

2.3 Market Constraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter’s Five Forces Analysis

3 Asia-Pacific Market Segmentation by Supply

3.1 Market Overview by Offer

3.2 CRISPR products

3.2.1 Kits and enzymes

3.2.2 Databases and libraries

3.2.3 Design tools

3.2.4 Antibodies

3.2.5 Plasmid and CRISPR vector

3.2.6 Other products

3.3 CRISPR Services

3.3.1 gRNA design and vector construction

3.3.2 Cell line engineering

3.3.3 Microbial gene editing

3.3.4 DNA synthesis

3.3.5 Other services

4 Asia-Pacific Market Segmentation by Application

4.1 Market Overview by Application

4.2 Biomedical research and therapy

4.2.1 Gene therapy

4.2.2 Drug discovery

4.2.3 Diagnosis

4.2.4 Other biomedical applications

4.3 Agriculture

4.4 Industrial use

4.5 Other applications

5 Asia-Pacific Market Segmentation by End User

5.1 Market Overview by End User

5.2 Pharmaceutical companies

5.3 Biotechnology companies

5.4 Academic Institutions and Research Centers

5.5 Other end users

6 Asia-Pacific Market 2021-2031 by Countries

6.1 Asia Pacific Market Overview

6.2 Japan

6.3 China

6.4 Australia

6.5 India

6.6 South Korea

6.7 Rest of the APAC region

7 Competitive landscape

7.1 Major Suppliers Overview

7.2 Launch of new products, partnership, investment and mergers and acquisitions

7.3 Company Profiles

For more information on this report, visit https://www.researchandmarkets.com/r/kpn8xy

Comments are closed.